arginine has been researched along with fibrinopeptide a in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (39.13) | 18.7374 |
| 1990's | 10 (43.48) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holmquist, R | 1 |
| Gorman, JJ | 1 |
| Bruhn, HD; Gram, J; Seydewitz, HH; Witt, I | 1 |
| Biasiutti, FD; Furlan, M; Lämmle, B; Leupin, L | 1 |
| Bauer, KA; Chin, DT; Clyne, LP; Kaczmarek, E; Lee, MH; McDonagh, J; McIntosh, S; Oda, A | 1 |
| Iwasaki, A; Kihara, H; Ohno, M; Shieh, TC; Shimohigashi, Y; Waki, M | 1 |
| Matsuo, T | 1 |
| Carr, ME; Qureshi, GD | 1 |
| Bell, WR; Ebert, RF; Schreiler, WE | 1 |
| Boissel, JP; Elion, J; Jandrot-Perrus, M; Josso, F; Rabiet, MJ | 1 |
| Beck, EA; Furlan, M; Rupp, C; Sievi, R | 1 |
| Deutsch, E; Henschen, A; Kehl, M | 1 |
| Garabedian, HD; Gold, HK; Hagstrom, JN; Jang, IK; Khan, A; Leinbach, RC; Newell, JB; Torres, FW; Werner, W; Yasuda, T | 1 |
| Kanbayashi, J; Matsuda, M; Sakon, M; Terukina, S; Tsujinaka, T; Yamazumi, K | 1 |
| Beck, EA; Furlan, M; Jungo, M; Lämmle, B; Steinmann, C | 1 |
| Edwards, BF; Lord, ST; Malkowski, MG; Martin, PD | 1 |
| Brennan, SO; George, PM; Hammonds, B; Spearing, R | 1 |
| Maruyama, I; Mohri, M; Sata, M; Sugimoto, E; Suzuki, M; Yamamoto, S | 1 |
| Akhavan, S; De Cristofaro, R; Landolfi, R; Lavoretano, S; Mannucci, PM; Peyvandi, F | 1 |
| PAGE, IH; SHAINOFF, JR | 1 |
| Akhavan, S; Altomare, C; Carotti, A; De Cristofaro, R; Mannucci, PM; Peyvandi, F | 1 |
| Betts, L; Bolliger-Stucki, B; Gorkun, OV; Kostelansky, MS; Lord, ST | 1 |
| Okumura, N; Soya, K; Takezawa, Y; Terasawa, F | 1 |
1 trial(s) available for arginine and fibrinopeptide a
| Article | Year |
|---|---|
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Topics: Aged; Angina, Unstable; Antithrombin III; Antithrombins; Arginine; Blood Coagulation; Drug Administration Schedule; Female; Fibrinopeptide A; Humans; Infusions, Intravenous; Male; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombin; Treatment Outcome | 1993 |
22 other study(ies) available for arginine and fibrinopeptide a
| Article | Year |
|---|---|
Deviations from compositional randomness in eukaryotic and prokaryotic proteins: the hypothesis of selective-stochastic stability and a principle of charge conservation.
Topics: Amino Acids; Animals; Arginine; Aspartic Acid; Bacillus; Bacterial Proteins; Biological Evolution; Cattle; Cytochrome c Group; Deoxyribonucleases; Fibrinopeptide A; Glutamate Dehydrogenase; Glutamates; Guinea Pigs; Humans; Insulin; Lysine; Probability; Proteins; Rabbits; Snakes; Species Specificity; Statistics as Topic; Stochastic Processes; Triose-Phosphate Isomerase; Viral Proteins | 1975 |
Inhibition of human thrombin assessed with different substrates and inhibitors. Characterization of fibrinopeptide binding interaction.
Topics: Arginine; Benzoylarginine Nitroanilide; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Hydroxylamines; Imidazoles; Phenylacetates; Phenylmethylsulfonyl Fluoride; Structure-Activity Relationship; Thrombin; Tosyllysine Chloromethyl Ketone; Tyrosine | 1975 |
Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
Topics: Amino Acids; Arginine; Blood Coagulation Disorders; Chromatography, High Pressure Liquid; Coagulase; Fibrinogens, Abnormal; Fibrinopeptide A; Histidine; Humans; Macromolecular Substances; Male; Middle Aged; Pedigree; Thrombin Time | 1991 |
[Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
Topics: Adult; Arginine; Blood Coagulation Disorders; Cysteine; Female; Fibrinogens, Abnormal; Fibrinopeptide A; Humans; Middle Aged; Pedigree; Prothrombin Time; Thrombin | 1991 |
Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
Topics: Amino Acid Sequence; Arginine; Blood Coagulation Disorders; Calcium; Child; Chromatography, High Pressure Liquid; Cysteine; Fibrinogens, Abnormal; Fibrinopeptide A; Fibrinopeptide B; Humans; Macromolecular Substances; Male; Molecular Sequence Data; Platelet Aggregation | 1991 |
Purification and characterization of a coagulant enzyme, okinaxobin I, from the venom of Trimeresurus okinavensis (Himehabu snake) which releases fibrinopeptide B.
Topics: Amino Acid Sequence; Animals; Arginine; Benzoylarginine Nitroanilide; Crotalid Venoms; Esterases; Fibrinopeptide A; Fibrinopeptide B; Hydrofluoric Acid; Isoelectric Point; Isoflurophate; Kinetics; Molecular Sequence Data; Molecular Weight; Phenylmethylsulfonyl Fluoride; Sequence Homology, Nucleic Acid; Serine Endopeptidases; Snakes; Substrate Specificity; Thrombin; Tosylarginine Methyl Ester; Tosyllysine Chloromethyl Ketone | 1990 |
[Clinical evaluation of MD-805].
Topics: Aged; Antithrombins; Arginine; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Fibrinopeptide A; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Renal Dialysis; Sulfonamides; Thrombocytopenia; Thrombosis | 1987 |
The impact of delayed fibrinopeptide-A release on fibrin structure. Studies of an abnormal fibrinogen.
Topics: Arginine; Batroxobin; Blood Coagulation; Fibrin; Fibrinogen; Fibrinopeptide A; Histidine; Humans; Nephelometry and Turbidimetry; Osmolar Concentration; Thrombin | 1987 |
Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
Topics: Afibrinogenemia; Amino Acids; Arginine; Chromatography, High Pressure Liquid; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Fibrinopeptide B; Histidine; Humans; Thrombin; Time Factors | 1986 |
Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin.
Topics: Antithrombin III; Arginine; Blood Coagulation; Dansyl Compounds; Enzyme Activation; Fibrinopeptide A; Fibrinopeptide B; Heparin; Humans; Hypoprothrombinemias; Kinetics; Platelet Aggregation; Prothrombin; Thrombin | 1984 |
[Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain].
Topics: Afibrinogenemia; Amino Acids; Arginine; Chemical Phenomena; Chemistry; Female; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Genetic Variation; Histidine; Humans; Male; Switzerland; Thrombin | 1983 |
Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach.
Topics: Amino Acids; Arginine; Chromatography, High Pressure Liquid; Cysteine; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Genetic Variation; Heterozygote; Humans | 1983 |
Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.
Topics: Afibrinogenemia; Amino Acid Sequence; Ancrod; Arginine; Chromatography, High Pressure Liquid; Fibrinogens, Abnormal; Fibrinopeptide A; Histidine; Humans; Male; Middle Aged; Molecular Sequence Data | 1993 |
Fibrinogen Claro--another dysfunctional fibrinogen variant with gamma 275 arginine-->histidine substitution.
Topics: Adult; Afibrinogenemia; Arginine; Base Sequence; Blood Protein Electrophoresis; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Histidine; Humans; Male; Molecular Sequence Data; Pedigree; Point Mutation | 1996 |
Crystal structure of fibrinogen-Aalpha peptide 1-23 (F8Y) bound to bovine thrombin explains why the mutation of Phe-8 to tyrosine strongly inhibits normal cleavage at Arg-16.
Topics: Animals; Arginine; Binding Sites; Cattle; Crystallography, X-Ray; Fibrinopeptide A; Molecular Sequence Data; Phenylalanine; Point Mutation; Protein Binding; Protein Conformation; Thrombin; Tyrosine | 1997 |
Electrospray ionisation mass spectrometry facilitates detection of fibrinogen (Bbeta 14 Arg --> Cys) mutation in a family with thrombosis.
Topics: Adult; Amino Acid Substitution; Arginine; Catalysis; Cysteine; Family Health; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Glycoproteins; Heterozygote; Humans; Mass Spectrometry; Molecular Weight; Mutation; Point Mutation; Polymerase Chain Reaction; Sequence Analysis; Thrombin; Thrombosis | 1997 |
Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma.
Topics: Antithrombins; Arginine; Blood Coagulation; Carboxypeptidase B2; Carboxypeptidases; Dalteparin; Dose-Response Relationship, Drug; Enzyme Activation; Fibrinopeptide A; Heparin; Humans; Pipecolic Acids; Protein C; Recombinant Fusion Proteins; Sulfonamides; Thrombelastography; Thrombin; Thrombomodulin | 1998 |
Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype.
Topics: Arginine; Blood Coagulation Disorders; Cell Line; Consanguinity; Factor Va; Factor Xa; Female; Fibrinopeptide A; Hemorrhagic Disorders; Heparin Cofactor II; Histidine; Homozygote; Humans; Hydrolysis; Infant; Mutagenesis, Site-Directed; Mutation; Protein C; Prothrombin; Receptor, PAR-1; Receptors, Thrombin; Thrombin; Thrombomodulin; Thromboplastin; Transfection | 2002 |
Significance of cryoprofibrin in fibrinogen-fibrin conversion.
Topics: Arginine; Blood Coagulation Factors; Cold Temperature; Fibrin; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Thrombin | 1962 |
A natural prothrombin mutant reveals an unexpected influence of A-chain structure on the activity of human alpha-thrombin.
Topics: Animals; Arginine; Blood Platelets; Catalytic Domain; Cell Membrane; Chromatography, High Pressure Liquid; COS Cells; DNA; Fibrinogen; Fibrinopeptide A; Gene Deletion; Humans; Hydrolysis; Hypoprothrombinemias; Ions; Kinetics; Lysine; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein C; Protein Conformation; Protein Structure, Secondary; Prothrombin; Sodium; Sodium Chloride; Thrombin; Time Factors; Transfection | 2004 |
B beta Glu397 and B beta Asp398 but not B beta Asp432 are required for "B:b" interactions.
Topics: Alanine; Arginine; Batroxobin; Calcium; Catalysis; Crystallography, X-Ray; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Glutamic Acid; Humans; Mutagenesis, Site-Directed; Polymers; Protein Binding; Protein Subunits; Recombinant Proteins; Thrombin | 2004 |
[Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg-->His (CGT-->CAT) with aberrant fibrinopeptide A release].
Topics: Adolescent; Adult; Afibrinogenemia; Arginine; Batroxobin; Catalysis; Child, Preschool; Female; Fibrinogens, Abnormal; Fibrinopeptide A; Histidine; Humans; Male; Mutation; Polymerization; Thrombin | 2012 |